Key result
This review discusses current guidelines, predictors, and clinical implications of permanent pacemaker implantation post-TAVR, proposing recommendations to reduce implantation rates.
Why the study?
What are the indications, timing, and risks of permanent pacemaker implantation in patients with conduction abnormalities post-TAVR?
What are the indications, timing, and risks of permanent pacemaker implantation in patients with conduction abnormalities post-TAVR?
This review synthesizes current evidence to propose guidelines and recommendations for managing conduction abnormalities and reducing permanent pacemaker implantation rates post-TAVR.
Guidelines on post-TAVR pacing remain inconclusive; leaves open optimal indications, timing, and risk mitigation for prospective trials.
Conduction abnormalities are a common and serious complication of transcatheter aortic valve replacement (TAVR) with well-established predictive factors. Current guidelines are not concrete, leaving several questions unanswered about indications, timing and risks of pacemaker implantation post-TAVR. In this review article, we discuss current guidelines, predictors of pacemaker implantation, clinical implications of this procedure and our recommendations for reducing the pacemaker implantation rate post-TAVR.
No takes yet. Share an insight, caveat, or question.
Bob‐Manuel et al. (2018) conducted a review in Conduction abnormalities post transcatheter aortic valve replacement. Permanent pacemaker insertion was evaluated. This review discusses current guidelines, predictors, and clinical implications of permanent pacemaker implantation post-TAVR, proposing recommendations to reduce implantation rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: